Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.925
Bid: 6.00
Ask: 7.85
Change: 0.00 (0.00%)
Spread: 1.85 (30.833%)
Open: 6.925
High: 0.00
Low: 0.00
Prev. Close: 6.925
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Year End Trading Update

11 Apr 2017 07:00

RNS Number : 0758C
Carclo plc
11 April 2017
 

 

 

Carclo plc

("Carclo" or the "Group") 

 

Year End Trading Update

 

The Board is pleased to confirm that, following the anticipated strong second half performance, the Group has delivered good growth for the year ended 31 March 2017, with trading in line with the Board's expectations.

 

Technical Plastics has delivered another year of growth and operating margin improvement, with margins expected to be at or close to the Group's stated 10% target. The integration of the recently acquired Precision Tool and Die business has progressed well, and the first tranche of synergistic projects is now underway. The Division's strategy of expanding its sites, increasing its penetration into the Global Top 20 medical device companies and driving margin enhancement is proceeding well.

 

The LED division's Wipac business has continued to win new lighting programmes and we are pleased to announce that we have been awarded a second mid-volume project, on a vehicle for the hybrid market. Reflecting its less complex design than the first mid-volume project, this programme is of lower value but does not require any material working capital investment by the Group. This win endorses our strategy to move into the mid-volume sector, in which the Board is confident of continued success.

 

The acquisition of FLTC (Europe) a.s. ("FLTC") was announced and completed on 30 March 2017 and the positive customer response to this extension of our capabilities has been very encouraging.

 

Group net debt at the year-end was broadly in line with our previous expectations, as adjusted for the net cash effect of the FLTC acquisition.

Carclo expects to report its preliminary results for the year ended 31 March 2017 on 6 June 2017.

 

The information contained within this announcement is deemed by Carclo plc to constitute inside information as stipulated under the Market Abuse Regulation. Upon the publication of this announcement via a regulatory information service, this inside information is now considered to be in the public domain.

 

Ends

For further information please contact:

Carclo plc

0192 426 8040

Chris Malley, Chief Executive

 

Robert Brooksbank, Finance Director

 

 

 

Peel Hunt LLP (Corporate broker)

020 7418 8900

Justin Jones

 

Matthew Brooke-Hitching

 

 

 

Weber Shandwick Financial (Financial PR)

020 7067 0700

Nick Oborne

 

 

About Carclo

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange.

Carclo's strategy is to develop and expand its key manufacturing assets in markets where there are significant further opportunities to drive shareholder value. To enhance profit margins and support its customers, the group has been investing across its global footprint.

Approximately three fifths of group revenues are generated from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of group revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the premium automotive industry.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTSFEFFSFWSEEL
Date   Source Headline
17th Apr 20247:55 amRNSDirectorate Change
15th Apr 20243:55 pmRNSHolding(s) in Company
28th Feb 20247:00 amRNSDirectorate Change
14th Feb 20247:00 amRNSStrategic Consolidation & Tucson Facility Closure
9th Feb 20241:15 pmRNSHolding(s) in Company
29th Jan 202411:09 amRNSDirectorate Change
23rd Jan 20244:48 pmRNSHolding(s) in Company
6th Dec 202310:53 amRNSHolding(s) in Company
30th Nov 20237:00 amRNSHalf-year Report
16th Nov 20237:00 amRNSNotice of Interim Results & Investor Presentation
25th Oct 20233:16 pmRNSCarclo Strategic Decision to Close Derry Facility
22nd Sep 20237:00 amRNSDirector/PDMR Shareholding
31st Aug 20234:01 pmRNSResult of AGM
31st Aug 20237:00 amRNSTrading Update
21st Aug 20231:09 pmRNSDirectorate Change
31st Jul 202311:42 amRNSAnnual Financial Report
18th Jul 20237:00 amRNSBanking covenant update
12th Jul 20237:00 amRNSFinal Results
7th Jul 20237:00 amRNSNotice of Investor Meet Presentation
23rd Jun 20237:00 amRNSBanking covenant adjustment
21st Jun 20231:08 pmRNSNotice of Results
30th May 202310:07 amRNSUpdate on contract cancellation
17th May 20238:46 amRNSHolding(s) in Company
12th May 20239:38 amRNSHolding(s) in Company
14th Apr 20237:00 amRNSTrading Statement
31st Mar 202312:50 pmRNSBanking Covenant update
9th Mar 20239:56 amRNSHolding(s) in Company
24th Feb 20237:00 amRNSDirectorate Change
6th Jan 20234:17 pmRNSHolding(s) in Company
19th Dec 20224:40 pmRNSSecond Price Monitoring Extn
19th Dec 20224:35 pmRNSPrice Monitoring Extension
16th Dec 20221:15 pmRNSDirector/PDMR Shareholding
16th Dec 20221:11 pmRNSDirector/PDMR Shareholding
16th Dec 20221:10 pmRNSDirector/PDMR Shareholding
15th Dec 20227:00 amRNSTrading Update
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
9th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20229:44 amRNSContract Cancellation
6th Dec 20226:29 pmRNSHolding(s) in Company - Replacement
5th Dec 20224:40 pmRNSSecond Price Monitoring Extn
5th Dec 20224:35 pmRNSPrice Monitoring Extension
30th Nov 20227:00 amRNSHalf-year Report
15th Nov 20227:05 amRNSNotice of Interim Results & Investor Presentation
15th Nov 20227:00 amRNSDirectorate Change
7th Nov 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSTrading Update
13th Oct 20221:22 pmRNSHolding(s) in Company
6th Oct 20221:05 pmRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.